PC
DPLO

Paulson & Co’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Paulson & Co’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-191,274
Closed -$5.24M – 99
2016
Q1 		$5.24M Sell
191,274
-18,726
-9% -$551K 0.04% 67
2015
Q4 		$7.19M Buy
+210,000
New +$6.55M 0.04% 54

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Paulson & Co's DPLO Position: Q2 2016 in Review

Paulson & Co sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2016, closing a stake of 191,274 shares — an estimated $5.24M sold.

Paulson & Co first reported a position in DPLO in Q4 2015 and held it in 2 quarters. The position peaked at $7.19M in Q4 2015. 166 funds tracked by Wall St. Rank hold DPLO as of Q2 2016.

  • Paulson & Co reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2016 after selling out during the quarter.
  • Paulson & Co sold 191,274 DIPLOMAT PHARMACY, INC. shares in Q2 2016, an estimated $5.24M.
  • Paulson & Co first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 2 quarters.
  • Paulson & Co's DIPLOMAT PHARMACY, INC. position peaked at $7.19M in Q4 2015.
  • 166 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2016.

Based on Paulson & Co's 13F filing for Q2 2016, filed 15 Aug 2016.